Literature DB >> 27498845

Brevibacterium massiliense (Roux and Raoult 2009) is a later heterotypic synonym of Brevibacterium ravenspurgense (Mages, Frodl, Bernard and Funke 2009), using whole-genome sequence analysis as a comparative tool.

Kathryn A Bernard1,2, Ana Luisa Pacheco2, Tamara Burdz2, Deborah Wiebe2, Chris Huynh2, Christine Bonner2, Greg J German3, Anne-Marie Bernier4.   

Abstract

A patient strain derived from urine was found by 16S rRNA gene sequencing to be closely related (99.6 % identity) to sequences derived from both Brevibacterium ravenspurgense CCUG 56047T and Brevibacterium massilienseCCUG 53855T. Those species had been described during the same 11 month period in 2008-2009. Further characterization revealed that those isolates could not be readily distinguished from each other biochemically, by cellular fatty acids, antimicrobial susceptibility, MALDI-TOF MS, 16S rRNA gene sequencing or by whole-genome sequence (WGS) analyses. By WGS comparison, these isolates had an aerage nucleotide identity using blastn (ANIb) scores of 95.7 % or higher to each other, DNA G+C content in the range of 62.3 mol%-62.4 mol%, with genome sizes ranging from 2.28×106 to 2.41×106 bases. Based on these data, we propose that the name B. massiliense is a later heterotypic synonym of B. ravenspurgense and provide an emended description of B. ravenspurgense.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27498845     DOI: 10.1099/ijsem.0.001371

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  2 in total

Review 1.  An Update on the Novel Genera and Species and Revised Taxonomic Status of Bacterial Organisms Described in 2016 and 2017.

Authors:  Erik Munson; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Draft whole-genome sequence of Brevibacterium casei strain isolated from a bloodstream infection.

Authors:  Alina Olender; Paweł Rutyna; Marcin Niemcewicz; Agnieszka Bogut; Marzanna Ciesielka; Grzegorz Teresiński
Journal:  Braz J Microbiol       Date:  2020-02-17       Impact factor: 2.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.